Published online before print August 3, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medicine, Division of Infectious Diseases, Children’s Hospital & Harvard Medical School, Boston, Massachusetts
1 Correspondence: Division of Infectious Diseases, Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115. E-mail: ofer.levy{at}tch.harvard.edu
Phagocytic leukocytes are a central cellular element of innate-immune defense in mammals. Over the past few decades, substantial progress has been made in defining the means by which phagocytes kill and dispose of microbes. In addition to the generation of toxic oxygen radicals and nitric oxide, leukocytes deploy a broad array of antimicrobial proteins and peptides (APP). The majority of APP includes cationic, granule-associated (poly)peptides with affinity for components of the negatively charged microbial cell wall. Over the past few years, the range of cells expressing APP and the potential roles of these agents have further expanded. Recent advances include the discovery of two novel families of mammalian APP (peptidoglycan recognition proteins and neutrophil gelatinase-associated lipocalin), that the oxygen-dependent and oxygen-independent systems are inextricably linked, that APP can be deployed in the context of novel subcellular organelles, and APP and the Toll-like receptor system interact. From a clinical perspective, congeners of several of the APP have been developed as potential therapeutic agents and have entered clinical trials with some evidence of benefit.
Key Words: neutrophil • polymorphonuclear leukocytes • defensins • cathelicidins • bactericidal/permeability-increasing protein (BPI) • lactoferrin • lysozyme • saponins • calprotectin • serprocidins • phospholipase A2 • Toll-like receptors
This article has been cited by other articles:
 |
|
 |
|
  D. L. Evans, M. A. Connor, L. D. Moss, S. Lackay, J. H. Leary III, T. Krunkosky, and L. Jaso-Friedmann Cellular expression and antimicrobial function of a phylogenetically conserved novel histone 1x-like protein on mouse cells: a potential new class of pattern recognition receptor J. Leukoc. Biol., July 1, 2009; 86(1): 133 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Di Gennaro, E. Kenne, M. Wan, O. Soehnlein, L. Lindbom, and J. Z. Haeggstrom Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin) FASEB J, June 1, 2009; 23(6): 1750 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Strunk, D Doherty, P Richmond, K Simmer, A Charles, O Levy, K Liyanage, T Smith, A Currie, and D Burgner Reduced levels of antimicrobial proteins and peptides in human cord blood plasma Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2009; 94(3): F230 - F231. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wu, S. A. McClellan, R. P. Barrett, and L. D. Hazlett {beta}-Defensin-2 Promotes Resistance against Infection with P. aeruginosa J. Immunol., February 1, 2009; 182(3): 1609 - 1616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kobayashi, T. Yoshida, D. Takeuchi, V. C. Jones, K. Shigematsu, D. N. Herndon, and F. Suzuki Gr-1+CD11b+ cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice J. Leukoc. Biol., June 1, 2008; 83(6): 1354 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Wittmann, M. Schonefeld, D. Aichele, G. Groer, A. Gessner, and M. Schnare Murine Bactericidal/Permeability-Increasing Protein Inhibits the Endotoxic Activity of Lipopolysaccharide and Gram-Negative Bacteria J. Immunol., June 1, 2008; 180(11): 7546 - 7552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gonzalez, Y. Gueguen, D. Destoumieux-Garzon, B. Romestand, J. Fievet, M. Pugniere, F. Roquet, J.-M. Escoubas, F. Vandenbulcke, O. Levy, et al. Evidence of a bactericidal permeability increasing protein in an invertebrate, the Crassostrea gigas Cg-BPI PNAS, November 6, 2007; 104(45): 17759 - 17764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Henneke and R. Berner Interaction of neonatal phagocytes with group B streptococcus: recognition and response. Infect. Immun., June 1, 2006; 74(6): 3085 - 3095. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lucas-Elio, D. Gomez, F. Solano, and A. Sanchez-Amat The Antimicrobial Activity of Marinocine, Synthesized by Marinomonas mediterranea, Is Due to Hydrogen Peroxide Generated by Its Lysine Oxidase Activity. J. Bacteriol., April 1, 2006; 188(7): 2493 - 2501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Nagaoka, H. Tamura, and M. Hirata An Antimicrobial Cathelicidin Peptide, Human CAP18/LL-37, Suppresses Neutrophil Apoptosis via the Activation of Formyl-Peptide Receptor-Like 1 and P2X7. J. Immunol., March 1, 2006; 176(5): 3044 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tomasinsig, B. Skerlavaj, N. Papo, B. Giabbai, Y. Shai, and M. Zanetti Mechanistic and Functional Studies of the Interaction of a Proline-rich Antimicrobial Peptide with Mammalian Cells J. Biol. Chem., January 6, 2006; 281(1): 383 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Feng, N. Huang, Q. Wu, and B. Wang HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes? J. Leukoc. Biol., November 1, 2005; 78(5): 1136 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. K. Harvey, E. G. Romanowski, K. A. Yates, and Y. J. Gordon Adenovirus-Directed Ocular Innate Immunity: The Role of Conjunctival Defensin-like Chemokines (IP-10, I-TAC) and Phagocytic Human Defensin-{alpha} Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3657 - 3665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol., May 1, 2005; 77(5): 598 - 625. [Abstract] [Full Text] [PDF]
|
|
